IL-11 in Adults With Von Willebrand Disease Undergoing Surgery

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine the efficacy and safety of rhIL-11 when given subcutaneously in adults with type 1 von Willebrand disease undergoing elective surgery or major dental procedure. Efficacy will be measured by estimated blood loss, and frequency and severity of bleeding and transfusion requirement during and after surgery. Safety will be measured by the frequency of adverse events, including fever, headache, fatigue, myalgias, arthralgias, fluid retention, or edema.

Clinical Trial Description

This study is a prospective, single-center Phase II trial of Neumega (rhIL-11) in adults with type 1 VWD undergoing elective surgery or major dental procedure. It is anticipated that 10 subjects who meet eligibility criteria will enroll and complete the study. The specific objectives are to determine the efficacy and safety or rhIL-11 during and after elective surgery, and to determine the mechanism of the hemostatic response of rhIL-11. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00524225
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Terminated
Phase	Phase 2
Start date	February 2008
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01651468` - The Effect of the Nutraceutical "Hemofix" on the Coagulation System	N/A
Active, not recruiting	`NCT00555555` - Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients	Phase 4
Terminated	`NCT00178542` - Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle	N/A
Completed	`NCT02552576` - Study of Voncento® in Subjects With Von Willebrand Disease	Phase 4
Recruiting	`NCT02869074` - Molecular and Clinical Profile of Von Willebrand Disease in Spain
Completed	`NCT01602419` - Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Completed	`NCT01224808` - Extension Study of Biostate in Subjects With Von Willebrand Disease	Phase 3
Withdrawn	`NCT00694785` - A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B	Phase 2
Completed	`NCT00805051` - Acquired Von Willebrand Syndrome in Severe Aortic Stenosis	N/A
Completed	`NCT02246881` - A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.	Phase 3
Completed	`NCT00168090` - Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)	Phase 4
Completed	`NCT04657887` - Registry of Patients With Von WilLEbrand Disease Treated With Voncento®
Withdrawn	`NCT00630448` - Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)	N/A
Terminated	`NCT00387192` - A Study With OPTIVATE® in People With Von Willebrand Disease	Phase 3
Completed	`NCT02973087` - rVWF IN PROPHYLAXIS	Phase 3
Completed	`NCT01410227` - Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)	Phase 3
Completed	`NCT01949220` - Willebrand International Non-interventional Global Surveillance
Completed	`NCT01589848` - Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador	N/A
Completed	`NCT00941616` - Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease	Phase 2/Phase 3
Completed	`NCT00557908` - The Von Willebrand Disease (VWD) International Prophylaxis Study	N/A